Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
Open Access
- 1 May 1997
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 25 (2) , 705-708
- https://doi.org/10.1042/bst0250705
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: